Network Bio builds AI on the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes from top US academic biobanks.
Location: United States
Total raised: $50M
Investors 1
| Date | Name | Website |
| 11.06.2023 | Breyer Cap... | breyercapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.08.2026 | - | $50M | Breyer Cap... |
Mentions in press and media 3
| Date | Title | Description |
| 20.08.2026 | Network Bio Launches with $50 Million Financing | PALO ALTO, CA, Network Bio, a biotechnology company, launched with $50 million in financing. >> Click here for more funding data on Network Bio >> To export Network Bio funding data to PDF and Excel, click here Network Bio, a b... |
| 19.08.2026 | Network Bio Raises $50M in Funding | Network Bio, a Boston, MA-based biotechnology company building disease-specific AI models from human biological data, raised $50M in financing. Backers included Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund, JSL He... |
| - | Network Bio | “Enabling computational biology for all human diseases. Network bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases.” |